Skip to main content

FDA Announces Safety Monitoring for Essure

By
Essure

The FDA is implementing a number of steps for long-term safety monitoring of the permanent birth control device Essure, which will no longer be sold or distributed in the U.S. after Dec. 31, 2018.



from WebMD Health https://wb.md/2rO8EWO
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Vitiligo: Treatment Options and Innovations

By
Vitiligo causes white patches on your skin that can affect your quality of life and even be emotionally devastating. Treatments include tried-and-true steroid creams, new immune-suppressing drugs, light therapy, and cell transplant surgery. from WebMD Health https://ift.tt/QBepsRw via IFTTT
Post a Comment
Read more

The Future of Autoimmune Disorders: Psoriatic Disease

By
What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT
Post a Comment
Read more

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

By
A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT
Post a Comment
Read more